GlassScriptPhysician profile
Glorimar Atiles
NPI 1295778025
$671.53
in general payments reported to CMS, 2019-2025
9 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.30 · 2020: $24.64 · 2021: $16.52 · 2023: $194 · 2024: $188 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $273.88 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $131.11 | 2021-2025 | Creon |
| Mimedx Group, INC. | $66.88 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $56.00 | 2024-2025 | Zenpep |
| Solventum Corporation | $36.35 | 2025 | V.A.C. Granufoam |
| Nestle Healthcare Nutrition INC. | $36.33 | 2023 | |
| Allergan, INC. | $24.64 | 2020 | |
| Tela Bio, INC. | $24.25 | 2024 | Ovitex 2s |
| Davol INC. | $22.09 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glorimar Atiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.